BioNTech Grapples with Falling Demand and Restructuring Post-Pandemic

BioNTech, once celebrated for its COVID-19 vaccines, is facing challenges including falling demand, restructuring, and the departure of its founders, as it shifts focus to ambitious cancer trials.

7 May, 13:03 — 7 May, 13:03

Post Share

Sources

Showing 1 of 1 sources

DWHigh1h ago

COVID pioneer BioNTech: The fall of Germany's pandemic hero

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?

Read full article →

PERSPECTA

PERSPECTA

BioNTech Grapples with Falling Demand and Restructuring Post-Pandemic

Sources

COVID pioneer BioNTech: The fall of Germany's pandemic hero

Related Stories

Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk

Latvia Completes €98.8 Million Modernization of Inčukalns Gas Storage Facility

Tech billionaire Chen Tianqiao’s MiroMind halts China services after Meta and Manus saga

Google Relaunches Fitness Services with Fitbit App and AI Integration

PERSPECTA